Myxedema Coma: A Life-Threatening Condition in Patients Using Pembrolizumab

The advent of immune checkpoint inhibitors has significantly improved the prognosis of patients with advanced malignancies. As we begin to understand these medications, multiple immune-related adverse effects (irAEs) have been found with these drugs, including endocrinopathies. Understanding the tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Gummalla, Sangeetha, Manjunath, Madhura, Phillips, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599411/
https://www.ncbi.nlm.nih.gov/pubmed/33145114
http://dx.doi.org/10.1155/2020/8855943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599411/
https://www.ncbi.nlm.nih.gov/pubmed/33145114
http://dx.doi.org/10.1155/2020/8855943

Ejemplares similares